Vena cava superior syndrome due to sternal plasmacytoma in the course of systemic myeloma.
Here we present a patient with multiple myeloma course. The first clinical manifestation was superior vena cava syndrome due to a huge sternal plasmocytoma. The patient was treated with a combination of high dose radiotherapy and autologous peripheral blood stem cell transplantation. We suggest careful evaluation of these patients with respect to aggressive therapy.
Saydam
Guray
G
Department of Internal Medicine, Division of Hematology, Faculty of Medicine, Ege University, Bornova, 35100 Izmir, Turkey. gsaydam@med.ege.edu.tr
Sahin
Fahri
F
Bozkurt
Devrim
D
Omay
Serdar Bedii
SB
Buyukkececi
Filiz
F
D001859:Bone Neoplasms / Q000150:complications*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications / Q000628:therapy; D036102:Peripheral Blood Stem Cell Transplantation; D010954:Plasmacytoma / Q000150:complications* / Q000628:therapy; D013249:Sternum; D013479:Superior Vena Cava Syndrome / Q000209:etiology*; D014182:Transplantation, Autologous